• / Free eNewsletters & Magazine
  • / My Account
Home>Shire Gains New Pinkeye Treatment With Deal For Eye-Drug Firm

Shire Gains New Pinkeye Treatment With Deal For Eye-Drug Firm

3party Content

Mon, 3 Aug 2015

(FROM THE WALL STREET JOURNAL 8/3/15) By Jonathan D. Rockoff Shire PLC has agreed to buy a privately held eye-drug company for $300 million in a deal that would add another promising ophthalmology treatment to a new line of business. The all-cash purchase of Foresight Biotherapeutics Inc., which
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.